Authors
Hyung Eun Bae, Jeong Soo Sung, Johyeon Nam, Min-Jung Kang, Han Soo Yoo, Joachim Jose, Misu Lee, Jae-Chul Pyun
Published in
International journal of biological macromolecules. Pages 155243. Nov 12, 2026. Epub Nov 12, 2026.
Abstract
α-Synuclein mimotopes were screened from an Fv-antibody library using a monoclonal anti-α-synuclein antibody and expressed as soluble Fv-antibodies. Their binding to the anti-α-synuclein antibody and TLR2 and their effects on TLR2 signaling were assessed using HEK-Blue hTLR2 cells. The α-synuclein oligomer and Pam3CSK4 induced strong secreted embryonic alkaline phosphatase (SEAP) signals, whereas mimotope-4 and mimotope-5 elicited only minimal downstream signaling, indicating TLR2 antagonistic activity. In HMC3, hAST, and SH-SY5Y cells, both mimotopes reduced α-synuclein oligomer-induced cytokine secretion and ROS production. Docking analysis showed that the α-synuclein oligomer and mimotopes bound to a similar LRR9-LRR12 region of TLR2, supporting competitive inhibition. Schild analysis further confirmed competitive antagonism by mimotope-4 and mimotope-5. Bulk RNA sequencing showed that genes altered by α-synuclein treatment shifted toward control levels following mimotope treatment. These recovered genes were associated with cell-type-specific inflammatory and survival pathways, including MAPK, NF-κB, cytokine-cytokine receptor interaction, and PI3K-Akt signaling. These results demonstrate that the mimotopes act as TLR2 antagonists by binding TLR2 without inducing downstream signaling and by reducing α-synuclein oligomer-induced TLR2-related inflammatory and transcriptional responses.
PMID:
43020357
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0